| Product specifications |
Information source:
Vendor
Last updated: Nov. 8, 2022 |
| General | |
|---|---|
| Product name | PAIRE |
| Company | PAIRE |
| Subspeciality | All indications covered by FDG PET-CT |
| Modality | CT, PET |
| Disease targeted | All diseases diagnosed through FDG PET-CT |
| Key-features | PET lesions detection, quantification, and segmentation |
| Suggested use | Before: flagging acute findings During: perception aid (prompting all abnormalities/results/heatmaps), report suggestion After: diagnosis verification |
| Data characteristics | |
| Population | Adults above 18 years old |
| Input | PET, CT, 3D, whole-body |
| Input format | DICOM |
| Output | Maximum Intensity Projection (MIP), series of key-images, overlay with lesions highlighted, table of quantifies values |
| Output format | DICOM Secondary Capture |
| Technology | |
| Integration | Integration in standard reading environment (PACS), Integration via AI marketplace or distribution platform |
| Deployment | Locally on dedicated hardware, Locally virtualized (virtual machine, docker), Cloud-based |
| Trigger for analysis | Automatically, right after the image acquisition, On demand, triggered by a user through e.g. a button click, image upload, etc. |
| Processing time | 1 - 10 minutes |
| Certification | |
|
CE
|
Certified,
Class I
, MDD
|
|
FDA
|
No or not yet |
| Market presence | |
| On market since | 05-2021 |
| Distribution channels | Incepto |
| Countries present (clinical, non-research use) | 1 |
| Paying clinical customers (institutes) | 6 |
| Research/test users (institutes) | 3 |
| Pricing | |
| Pricing model | Subscription |
| Based on | Number of analyses |
| Evidence | |
| Peer reviewed papers on performance | |
| Non-peer reviewed papers on performance | |
| Other relevant papers | |